Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0121008 Method and Apparatus for Rapid Sterilization of Hazmat Suits, Surgical Instruments and the Like
Methods and systems for sterilization are disclosed, including placing one or more UV light sources located substantially at one or more foci of a...
2016/0121007 OBJECT DECONTAMINATION APPARATUS AND METHOD
Provided is a decontamination apparatus including a base, and a source that emits UVC light at a suitable intensity to at least partially decontaminate a...
2016/0121006 HANDHELD ELECTRONIC DEVICE AND ANTIBACTERIAL METHOD OF THE SAME
A handheld electronic device having an antibacterial mechanism is provided. The handheld electronic device includes a main body, a display panel and a...
2016/0121005 FILTER AND CONTAINER HAVING MICROBICIDAL ACTIVITY
A sterilization filter includes a synthetic polymer film, the synthetic polymer film having a surface which has a plurality of first raised portions, a...
2016/0121004 NOVEL GRP-R AGONISTIC 177-LUTETIUM-LABELED BOMBESIN DERIVATIVES FOR DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
Provided is a novel compound capable of being usefully used to diagnose and treat prostate cancer by labeling a radioisotope on a bombesin derivatives capable...
2016/0121003 METHODS FOR DIAGNOSING AND MONITORING TREATMENT OF LEWY BODY DEMENTIA BY ASSESSING DOPAMINE TRANSPORTER LEVEL
A method of diagnosing Lewy Body Dementia in a human patient by assessing the level of dopamine transporter in at least one region of the patient's central...
2016/0121002 Bioorthogonal Turn-on Probes
This present application relates to fluorescent tetrazine-containing compounds consisting of a single pi-system. For example, a compound of Formula (I): or a...
2016/0121001 METHODS OF INDUCING RESPONSIVENESS TO ANTI-ANGIOGENIC AGENT
The invention provides methods of inducing or improving responsiveness to a VEGF antagonist to a subject or a subject population comprising administering an...
2016/0121000 METHOD FOR PREPARING NANOHYDROGEL
A method for preparing nanohydrogels comprising a dispersion step, in which a polysaccharide functionalized with hydrophobic molecules and in the form of a...
2016/0120999 COMPOSITIONS AND METHODS OF USE FOR TREATING METABOLIC DISORDERS
A complex comprising a GDF15 polypeptide is described. Methods of treating individuals with a metabolism disorder, such as, glucose metabolism disorder and/or...
2016/0120998 Cell-Penetrating Drug Carrier and the Application Thereof
This invention is about a cell-penetrating drug carrier and the application thereof. The mentioned cell-penetrating drug carrier can approach the target cell...
2016/0120997 Modified Glycoproteins Having Circulating Half-Lives
Method of conjugating glycoproteins by means of chemical modification is provided as well as new modified glycoproteins.
2016/0120996 COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES
A novel delivery system for drugs, and especially macromolecules such as proteins or oligonucleotides through biological membranes is provided, and...
2016/0120995 CONJUGATES OF POLYUNSATURATED FATTY ACIDS AND AMINE-CONTAINING COMPOUNDS AND USES THEREOF
Novel chemical conjugates derived from unsaturated fatty acids and therapeutically active agents, are disclosed. The chemical conjugates are designed and...
2016/0120994 BLOOD COAGULATION PROTEIN CONJUGATES
The invention relates to materials and methods of conjugating a water soluble polymer to an oxidized carbohydrate moiety of a blood coagulation protein...
2016/0120993 Activated Sialic Acid Derivatives For Protein Derivatisation And Conjugation
Derivatives of PSAs are synthesised, in which a reducing and/or non-reducing end terminal sialic acid unit is transformed into a N-hydroxysuccinimide (NHS)...
2016/0120992 COAGULATION FACTOR VII POLYPEPTIDES
The present invention relates to modified coagulation Factor VII polypeptides exhibiting increased resistance to antithrombin inactivation and enhanced...
2016/0120991 SELF-ASSOCIATING MICROPARTICLES AND NANOPARTICLES CONSISTING OF PROTEINS
Microparticles and nanoparticles of hydrophobized proteins and an alpha-cyclodextrin, obtained by auto-association in an aqueous medium, the hydrophobized...
2016/0120990 COMPOSITION FOR APPLICATION TO A MUCOSA COMPRISING A HYDROXYALKYL METHYLCELLULOSE
A composition designed for application to a mucosa comprises a tonicity-adjusting agent, a hydroxyalkyl methylcellulose and a liquid diluent, wherein the...
2016/0120989 COPROCESSED SILICA COATED POLYMER COMPOSITION
An excipient composition having good bulk density and improved flow characteristics is provided. The present invention particularly provides a coprocessed...
2016/0120988 PAZOPANIB FORMULATION
A granulation formulation of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-- methylbenzenesulfonamide or pharmaceutically acceptable...
2016/0120987 CHEMICAL STRUCTURES FOR LOCALIZED DELIVERY OF THERAPEUTIC AGENTS
The present invention provides a method for selective delivery of a therapeutic or diagnostic agent to a targeted organ or tissue by implanting a biocompatible...
2016/0120986 DELIVERY SYSTEMS
Disclosed herein are delivery systems including coated and uncoated yarns, yarn precursors, threads, fibers, and other substrates for the constant or...
2016/0120985 MOLECULAR ASSEMBLY USING AMPHIPATHIC BLOCK POLYMER, AND SUBSTANCE-CONVEYANCE CARRIER USING SAME
Provided is a molecular assembly having any nano-sized particle diameter depending on its intended use and application, in various fields such as ...
2016/0120984 SUGAR CONTAINING, AMPHIPHILIC COPOLYMERS
Disclosed herein are polymers made from at least one monomer of formulae (I), (II), (III), and (IV), in combination with a monomer of formula (V) that may be...
2016/0120983 PHARMACEUTICAL COMPOSITION WITH INCREASED SOLUBILITY BY USING SACCHARIN
The present invention provides a pharmaceutical composition including an ionic liquid composed of a triptan compound and saccharin. Since a triptan compound...
2016/0120982 VACCINE STABILIZER
Disclosed herein is a formulation capable of enhancing thermostability and shelf-life of a biological product, the formulation comprising: a tertiary amine...
2016/0120981 HYALURONIC ACID STABILIZER
An embodiment of the present disclosure provides a composition that comprises hyaluronic acid, or its salt or derivative thereof, and an antimicrobial agent,...
2016/0120980 REGIONAL CANCER THERAPY
This invention relates to compositions and methods of treating cancers, and more particularly to regional delivery of cancer therapy compositions on...
2016/0120979 METHOD OF APPLYING A COMPOSITION AND PHARMACEUTICAL COMPOSITION WITH A REGIMEN OF ADMINISTERING IT
A method applying a composition to a human or non-human individual or to an object or a surface area and a pharmaceutical composition with a regimen of...
2016/0120978 TITANIUM NITRIDE PLASMONIC NANOPARTICLES FOR CLINICAL THERAPEUTIC APPLICATIONS
Disclosed herein are nanoparticle-based plasmonic solutions to therapeutic applications employing titanium nitride (TiN) and other non-stoichiometric compounds...
2016/0120977 PROTEINS MODIFIED WITH (AMINO) MONOSACCHARIDE-BIOTIN ADDUCT
A protein, e.g. an antibody, coated with a non-immunogenic molecule selected from an amino-monosaccharide-biotin adduct or a monosaccharide-biotin adduct is...
2016/0120976 COMBINATION THERAPY WITH ANTI-CD74 AND ANTI-CD20 ANTIBODIES IN PATIENTS WITH RELAPSED AND REFRACTORY B-CELL...
The present invention concerns methods of treating relapsed/resistant non-Hodgkin's lymphoma using combination therapy with an anti-CD20 antibody or fragment...
2016/0120975 FISH VACCINE
A composition comprising a translocation sequence derived from a fish pathogen and a heterologous payload coupled to the translocation sequence is provided....
2016/0120974 SEMI-LIVE RESPIRATORY SYNCYTIAL VIRUS VACCINE
The present invention relates to a semi-live respiratory syncytial virus (RSV) vaccine, which comprises a genome replication-deficient Sendai virus (SeV)...
2016/0120973 Attenuated Swine Influenza Vaccines and Methods of Making and Use Thereof
This disclosure provides attenuated swine influenza strains, particularly those produced via a reverse genetics approach, compositions comprising same, and...
2016/0120972 INACTIVATED DENGUE VIRUS VACCINE WITH ALUMINIUM-FREE ADJUVANT
The present disclosure provides immunogenic compositions for the prevention and/or treatment of disease caused by dengue virus.
2016/0120971 IMMUNOGENIC COMPOSITION COMPRISING NEISSERIA MENINGITIDIS MACROPHAGE INFECTIVITY POTENTIATOR PROTEIN AND...
An immunogenic composition comprising the Nm-MIP protein or an immunogenic part thereof or an analogue thereof, wherein the composition is capable of eliciting...
2016/0120970 COMPOUNDS AND METHODS FOR AFFECTING CYTOKINES
The present invention discloses isolates and fractions from a phyto-percolate and methods for affecting various cytokines by administering an effective amount...
2016/0120969 COMBINATION VACCINE
The disclosure relates to a composition comprising two or more immunogenic staphylococcal polypeptides and a multivalent vaccine composition comprising the...
2016/0120968 Compositions and Methods for Immunizing Against C. Difficile
This disclosure relates to methods for eliciting an immune response against C. difficile toxin A and toxin B in an adult human subject. The subject may be at...
2016/0120967 MODIFIED ENDOTOXIC BACTERIA LIPOPOLYSACCHARIDE (VARIANTS), COMBINATION OF MODIFIED LIPOPOLYSACCHARIDES...
For the first time individual (free from impurities of penta- and hexa-acetylated derivatives) di-, tri- and tetra-acetylated S-LPS of endotoxic bacteria and...
2016/0120966 BIOLOGICAL MARKERS USEFUL IN CANCER IMMUNOTHERAPY
Methods are disclosed that are based on the finding that serum and plasma levels of eotaxin, MIP1.alpha., and CRP act as important biomarkers that are useful...
2016/0120965 VACCINE PEPTIDE COMBINATIONS AGAINST CAT ALLERGY
The present invention relates to compositions comprising peptides for preventing or treating allergy to cats, and in particular to optimal combinations of...
2016/0120964 PROCESSES FOR PRODUCING COMPOSITIONS WITH IMPROVED SAFETY PROFILE HAVING LIPASE ACTIVITY AND COMPOSITIONS...
Processes are described for producing solid or semi-solid compositions, in particular solid oral compositions for pharmaceutical use, comprising treating an...
2016/0120963 BILE SALT HYDROLASE BSH1 FOR REGULATING WEIGHT GAIN, SERUM CHOLESTEROL LEVELS, AND LIVER TRIGLYCERIDES IN A...
A non-therapeutic method of reducing weight gain, serum cholesterol levels, or liver triglyceride levels, in a non-obese mammal, comprises the step of...
2016/0120962 APOBEC3A AS AN ANTI-TUMOR AGENT
The present invention relates to the use of a nucleic acid that comprises a sequence encoding an APOBEC3A protein, in preventing or treating a tumor in a patient.
2016/0120961 TREATMENT OF MERKEL CELL POLYOMAVIRUS INFECTION
The present disclosure provides novel compositions and methods for treating an infection of the skin resulting from an infection of a member of the...
2016/0120960 ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO THE CENTRAL NERVOUS SYSTEM
A method to prevent, inhibit or treat one or more symptoms associated with a disease of the central nervous system by intrathecally, intracerebroventricularly...
2016/0120959 Use of Klotho Nucleic Acids or Proteins for Treatment of Diabetes and Diabetes-Related Conditions
In one embodiment, the inventive concepts include a method of treating a diabetic condition or a diabetes-related condition in a subject in need of such...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.